<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="article-commentary" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">29942</article-id><article-id pub-id-type="doi">10.7554/eLife.29942</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Insight</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group><subj-group subj-group-type="sub-display-channel"><subject>Post-translational modifications</subject></subj-group></article-categories><title-group><article-title>Reversing ADP-ribosylation</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-94152"><name><surname>Moeller</surname><given-names>Giuliana Katharina</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2006-2335</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Giuliana Katharina Moeller</bold> is in the Department of Physiological Chemistry, Biomedical Center Munich, Ludwig-Maximilians-Universität München, Munich, Germany</p></bio></contrib><contrib contrib-type="author" corresp="yes" id="author-14160"><name><surname>Timinszky</surname><given-names>Gyula</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6342-8985</contrib-id><email>gyula.timinszky@med.uni-muenchen.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/><bio><p><bold>Gyula Timinszky</bold> is in the Department of Physiological Chemistry, Biomedical Centre Munich, Ludwig-Maximilians-Universität München, Munich, Germany and the Institute of Genetics, Biological Research Center of the Hungarian Academy of Sciences, Szeged, Hungary</p></bio></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Physiological Chemistry</institution><institution>Ludwig-Maximilians-University of Munich</institution><addr-line><named-content content-type="city">Munich</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Institute of Genetics</institution><institution>Biological Research Center of the Hungarian Academy of Sciences</institution><addr-line><named-content content-type="city">Szeged</named-content></addr-line><country>Hungary</country></aff></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>10</day><month>08</month><year>2017</year></pub-date><pub-date pub-type="collection"><year>2017</year></pub-date><volume>6</volume><elocation-id>e29942</elocation-id><history><date date-type="received" iso-8601-date="2017-08-03"><day>03</day><month>08</month><year>2017</year></date><date date-type="accepted" iso-8601-date="2017-08-03"><day>03</day><month>08</month><year>2017</year></date></history><permissions><copyright-statement>© 2017, Moeller et al</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Moeller et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-29942-v1.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="commentary-article" xlink:href="10.7554/eLife.28533"/><related-object ext-link-type="url" xlink:href="https://elifesciences.org/articles/e29942v1"><date date-type="v1" iso-8601-date="2017-08-10"><day>10</day><month>08</month><year>2017</year></date></related-object><abstract><p>The modification of serines by molecules of ADP-ribose plays an important role in signaling that the DNA in a cell has been damaged and needs to be repaired.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>PARP</kwd><kwd>ADP-ribosylation</kwd><kwd>ARH3</kwd><kwd>ADP-ribose</kwd><kwd>macrodomain</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Interactions between serines and molecules of ADP-ribose play an important role in signaling that the DNA in a cell has been damaged and needs to be repaired.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><boxed-text><p><bold>Related research article</bold> Fontana P, Bonfiglio JJ, Palazzo L, Bartlett E, Matic I, Ahel I. 2017. Serine ADP-ribosylation reversal by the hydrolase ARH3. <italic>eLife</italic> <bold>6</bold>:e28533. doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7554/eLife.28533">10.7554/eLife.28533</ext-link></p></boxed-text><p>Cells rapidly react to stimuli in their environment by making modifications to proteins that change the way those proteins interact with other molecules (<xref ref-type="bibr" rid="bib8">Mann and Jensen, 2003</xref>). Once a stimulus has stopped, these 'post-translational modifications' are usually reversed and the cell’s life goes back to normal. For example, when a cell suffers damage to its DNA, the addition of a molecule called ADP-ribose – a process that is known as ADP-ribosylation – to certain proteins sends a signal that leads to the damage being repaired; drugs that inhibit the addition of ADP-ribose are also used in cancer therapy (see <xref ref-type="bibr" rid="bib7">Li and Yu, 2015</xref> for a review).</p><p>It was discovered in the 1960s that specialized enzymes called PARPs can add one or more units of ADP-ribose (ADPr) to specific amino acids within proteins. Over the decades, it became clear that these enzymes are involved in a wide range of cellular processes, including DNA repair, transcription, chromatin regulation and cell death. The first target sites for ADP-ribosylation to be identified were mostly glutamates, aspartates and lysines, and the enzymes responsible for the removal of the ADPr units were also established (<xref ref-type="fig" rid="fig1">Figure 1</xref>)(<xref ref-type="bibr" rid="bib1">Barkauskaite et al., 2013</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Mono- and poly(ADP-ribosyl)ation and their reversal.</title><p>When a protein (top) undergoes mono(ADP-ribosyl)ation the ADP-ribose (red circle) can be added to a glutamate (Glu) or aspartate (Asp; left) or a serine (Ser; right). It is also possible for multiple units of ADP-ribose to be added to a protein at a given target site in a process known as poly(ADP-ribosyl)ation (bottom). The enzymes PARP1 and PARP2 are involved in ADP-ribosylation of both Glu/Asp and Ser, with a protein called HPF1 acting as a cofactor in the mono(ADP-ribosyl)ation of Ser. The enzymes involved in the reversal of both mono- and poly(ADP-ribosyl)ation are shown. Fontana et al. have shown that ARH3 is exclusively responsible for reversing the mono(ADP-ribosyl)ation of Ser, and that it is also involved (with PARG) in reversing the poly(ADP-ribosyl)ation of Ser.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-29942-fig1-v1"/></fig><p>More recently, it was shown that serines can be target sites for ADP-ribosylation, and that many of the proteins that contain such target sites have important roles in DNA damage repair (<xref ref-type="bibr" rid="bib2">Bilan et al., 2017</xref>; <xref ref-type="bibr" rid="bib3">Bonfiglio et al., 2017</xref>; <xref ref-type="bibr" rid="bib6">Leidecker et al., 2016</xref>; <xref ref-type="bibr" rid="bib5">Gibbs-Seymour et al., 2016</xref>). However, nothing was known about the enzymes or mechanisms responsible for the removal of the ADPr units from the serines. Now, in eLife, Ivan Ahel of the University of Oxford, Ivan Matic of the Max Planck Institute for Biology of Ageing in Cologne and co-workers – including Pietro Fontana, Juan José Bonfiglio and Luca Palazzo as joint first authors, along with Edward Bartlett – provide new insight into these matters (<xref ref-type="bibr" rid="bib4">Fontana et al., 2017</xref>).</p><p>Using biochemical approaches and a technique called mass spectrometry, Fontana et al. screened a number of proteins that are known to bind to ADPr to find out if they could remove ADPr units that had been added to serines. They discovered that an enzyme called ARH3 could remove ADPr from serine on histone proteins (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Previous research has shown that ARH3 and PARG work in similar ways. Both enzymes are able to break the ribose bonds that hold chains of ADPr units together, but ARH3 hydrolyses the chains less efficiently than PARG and also has a different structure (<xref ref-type="bibr" rid="bib9">Mueller-Dieckmann et al., 2006</xref>; <xref ref-type="bibr" rid="bib10">Oka et al., 2006</xref>). Fontana et al. discovered that unlike PARG, ARH3 was able to cleave both single ADPr units and chains of ADPr on histones and other proteins.</p><p>Since mass spectrometry is a rather expensive and laborious technique, Fontana et al. also used ARH3 in combination with western blotting – a basic technique to detect specific proteins or protein modifications – to track ADP-ribosylation on serines. These experiments confirmed the findings obtained with mass spectrometry, and proved that histone proteins are primarily – if not exclusively – modified on serine. Future studies could build on these findings and use ARH3 as a tool to detect the ADP-ribosylation of serines in proteins.</p><p>Despite these new insights, many outstanding questions remain. For example, how does adding ADPr to serine affect the role of a protein? And what happens when two neighboring amino acids experience post-translational modifications? A widely studied post-translational modification that regulates gene expression involves the methylation or acetylation of two lysines (K9 and K27) in histone three (<xref ref-type="bibr" rid="bib11">Saksouk et al., 2015</xref>). However, these lysines are followed by a serine, which could undergo its own post-translation modification (which could be phosphorylation or ADP-ribosylation). Would these modifications influence each other? Probably, yes. This complex interplay may have far reaching consequences in the regulation of gene expression, and may play an important role in many diseases that depend on ADP-ribosylation pathways.</p></body><back><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barkauskaite</surname> <given-names>E</given-names></name><name><surname>Jankevicius</surname> <given-names>G</given-names></name><name><surname>Ladurner</surname> <given-names>AG</given-names></name><name><surname>Ahel</surname> <given-names>I</given-names></name><name><surname>Timinszky</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The recognition and removal of cellular poly(ADP-ribose) signals</article-title><source>FEBS Journal</source><volume>280</volume><fpage>3491</fpage><lpage>3507</lpage><pub-id pub-id-type="doi">10.1111/febs.12358</pub-id><pub-id pub-id-type="pmid">23711178</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bilan</surname> <given-names>V</given-names></name><name><surname>Leutert</surname> <given-names>M</given-names></name><name><surname>Nanni</surname> <given-names>P</given-names></name><name><surname>Panse</surname> <given-names>C</given-names></name><name><surname>Hottiger</surname> <given-names>MO</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Combining higher-energy collision dissociation and electron-transfer/higher-energy collision dissociation fragmentation in a product-dependent manner confidently assigns proteomewide ADP-ribose acceptor sites</article-title><source>Analytical Chemistry</source><volume>89</volume><fpage>1523</fpage><lpage>1530</lpage><pub-id pub-id-type="doi">10.1021/acs.analchem.6b03365</pub-id><pub-id pub-id-type="pmid">28035797</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonfiglio</surname> <given-names>JJ</given-names></name><name><surname>Fontana</surname> <given-names>P</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Colby</surname> <given-names>T</given-names></name><name><surname>Gibbs-Seymour</surname> <given-names>I</given-names></name><name><surname>Atanassov</surname> <given-names>I</given-names></name><name><surname>Bartlett</surname> <given-names>E</given-names></name><name><surname>Zaja</surname> <given-names>R</given-names></name><name><surname>Ahel</surname> <given-names>I</given-names></name><name><surname>Matic</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Serine ADP-ribosylation depends on HPF1</article-title><source>Molecular Cell</source><volume>65</volume><fpage>932</fpage><lpage>940</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2017.01.003</pub-id><pub-id pub-id-type="pmid">28190768</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname> <given-names>P</given-names></name><name><surname>Bonfiglio</surname> <given-names>JJ</given-names></name><name><surname>Palazzo</surname> <given-names>L</given-names></name><name><surname>Bartlett</surname> <given-names>E</given-names></name><name><surname>Matic</surname> <given-names>I</given-names></name><name><surname>Ahel</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Serine ADP-ribosylation reversal by the hydrolase ARH3</article-title><source>eLife</source><volume>6</volume><elocation-id>e28533</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.28533</pub-id><pub-id pub-id-type="pmid">28650317</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs-Seymour</surname> <given-names>I</given-names></name><name><surname>Fontana</surname> <given-names>P</given-names></name><name><surname>Rack</surname> <given-names>JG</given-names></name><name><surname>Ahel</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>HPF1/C4orf27 is a PARP-1-interacting protein that regulates PARP-1 ADP-ribosylation activity</article-title><source>Molecular Cell</source><volume>62</volume><fpage>432</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2016.03.008</pub-id><pub-id pub-id-type="pmid">27067600</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leidecker</surname> <given-names>O</given-names></name><name><surname>Bonfiglio</surname> <given-names>JJ</given-names></name><name><surname>Colby</surname> <given-names>T</given-names></name><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Atanassov</surname> <given-names>I</given-names></name><name><surname>Zaja</surname> <given-names>R</given-names></name><name><surname>Palazzo</surname> <given-names>L</given-names></name><name><surname>Stockum</surname> <given-names>A</given-names></name><name><surname>Ahel</surname> <given-names>I</given-names></name><name><surname>Matic</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Serine is a new target residue for endogenous ADP-ribosylation on histones</article-title><source>Nature Chemical Biology</source><volume>12</volume><fpage>998</fpage><lpage>1000</lpage><pub-id pub-id-type="doi">10.1038/nchembio.2180</pub-id><pub-id pub-id-type="pmid">27723750</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>M</given-names></name><name><surname>Yu</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapy</article-title><source>Oncogene</source><volume>34</volume><fpage>3349</fpage><lpage>3356</lpage><pub-id pub-id-type="doi">10.1038/onc.2014.295</pub-id><pub-id pub-id-type="pmid">25220415</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mann</surname> <given-names>M</given-names></name><name><surname>Jensen</surname> <given-names>ON</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Proteomic analysis of post-translational modifications</article-title><source>Nature Biotechnology</source><volume>21</volume><fpage>255</fpage><lpage>261</lpage><pub-id pub-id-type="doi">10.1038/nbt0303-255</pub-id><pub-id pub-id-type="pmid">12610572</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller-Dieckmann</surname> <given-names>C</given-names></name><name><surname>Kernstock</surname> <given-names>S</given-names></name><name><surname>Lisurek</surname> <given-names>M</given-names></name><name><surname>von Kries</surname> <given-names>JP</given-names></name><name><surname>Haag</surname> <given-names>F</given-names></name><name><surname>Weiss</surname> <given-names>MS</given-names></name><name><surname>Koch-Nolte</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The structure of human ADP-ribosylhydrolase 3 (ARH3) provides insights into the reversibility of protein ADP-ribosylation</article-title><source>PNAS</source><volume>103</volume><fpage>15026</fpage><lpage>15031</lpage><pub-id pub-id-type="doi">10.1073/pnas.0606762103</pub-id><pub-id pub-id-type="pmid">17015823</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oka</surname> <given-names>S</given-names></name><name><surname>Kato</surname> <given-names>J</given-names></name><name><surname>Moss</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Identification and characterization of a mammalian 39-kDa poly(ADP-ribose) glycohydrolase</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>705</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1074/jbc.M510290200</pub-id><pub-id pub-id-type="pmid">16278211</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saksouk</surname> <given-names>N</given-names></name><name><surname>Simboeck</surname> <given-names>E</given-names></name><name><surname>Déjardin</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Constitutive heterochromatin formation and transcription in mammals</article-title><source>Epigenetics &amp; Chromatin</source><volume>8</volume><elocation-id>3</elocation-id><pub-id pub-id-type="doi">10.1186/1756-8935-8-3</pub-id><pub-id pub-id-type="pmid">25788984</pub-id></element-citation></ref></ref-list></back></article>